Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis

INTRODUCTION: Erythropoiesis-stimulating agents are associated with increased cardiovascular risk when higher doses are used toward higher hematocrit targets. Patients new to dialysis are at higher risk for morbidity and mortality. Systematic evaluation of this population was predefined in the roxad...

Descripción completa

Detalles Bibliográficos
Autores principales: Provenzano, Robert, Fishbane, Steven, Szczech, Lynda, Leong, Robert, Saikali, Khalil G., Zhong, Ming, Lee, Tyson T., Houser, Mark T., Frison, Lars, Houghton, John, Little, Dustin J., Peony Yu, Kin-Hung, Neff, Thomas B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938204/
https://www.ncbi.nlm.nih.gov/pubmed/33732976
http://dx.doi.org/10.1016/j.ekir.2020.12.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938204/
https://www.ncbi.nlm.nih.gov/pubmed/33732976
http://dx.doi.org/10.1016/j.ekir.2020.12.018

Ejemplares similares